![Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Neurology Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Neurology](https://www.thelancet.com/cms/asset/c709a625-668f-411d-ba24-4c875e24aefa/gr1a.jpg)
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Neurology
![In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study - The Lancet Respiratory Medicine In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/4b35c5bf-caea-4728-88b2-f07e3008a58d/gr1.jpg)
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study - The Lancet Respiratory Medicine
![Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial - The Lancet Oncology Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/asset/ebf9c17b-7269-4c6d-ba49-4dad8ba06853/gr1.jpg)
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial - The Lancet Oncology
![Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study - The Lancet Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study - The Lancet](https://www.thelancet.com/cms/asset/d844b3f4-9d6e-4d07-9aac-4c6f3e6e43a8/gr1.jpg)
Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study - The Lancet
![Sympathetic axonal sprouting induces changes in macrophage populations and protects against pancreatic cancer | Nature Communications Sympathetic axonal sprouting induces changes in macrophage populations and protects against pancreatic cancer | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-29659-w/MediaObjects/41467_2022_29659_Fig1_HTML.png)
Sympathetic axonal sprouting induces changes in macrophage populations and protects against pancreatic cancer | Nature Communications
![Preservation of early Tonian macroalgal fossils from the Dolores Creek Formation, Yukon | Scientific Reports Preservation of early Tonian macroalgal fossils from the Dolores Creek Formation, Yukon | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-10223-x/MediaObjects/41598_2022_10223_Fig1_HTML.png)
Preservation of early Tonian macroalgal fossils from the Dolores Creek Formation, Yukon | Scientific Reports
![Mechanisms of three-dimensional growth of thyroid cells during long-term simulated microgravity | Scientific Reports Mechanisms of three-dimensional growth of thyroid cells during long-term simulated microgravity | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep16691/MediaObjects/41598_2015_Article_BFsrep16691_Fig1_HTML.jpg)